APA (7th ed.) Citation

Luo, X., Duan, Y., He, J., Huang, C., Liu, J., Liu, Y., . . . Yang, Z. Dihydrotanshinone I enhanced BRAF mutant melanoma treatment efficacy by inhibiting the STAT3/SOX2 signaling pathway. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Luo, Xing, Yi Duan, Jinwei He, CongGai Huang, Jun Liu, Yifan Liu, Mengdei Xu, Qiong Dai, and Zhihui Yang. Dihydrotanshinone I Enhanced BRAF Mutant Melanoma Treatment Efficacy by Inhibiting the STAT3/SOX2 Signaling Pathway. Frontiers Media S.A.

MLA (9th ed.) Citation

Luo, Xing, et al. Dihydrotanshinone I Enhanced BRAF Mutant Melanoma Treatment Efficacy by Inhibiting the STAT3/SOX2 Signaling Pathway. Frontiers Media S.A.